{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:16:29Z","timestamp":1794474989205,"version":"4.9.1"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001288","name":"Parkinson's Foundation Inc","doi-asserted-by":"publisher","award":["PF-SF-JFA-1040267"],"award-info":[{"award-number":["PF-SF-JFA-1040267"]}],"id":[{"id":"10.13039\/100001288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006309","name":"American Parkinson Disease Association","doi-asserted-by":"publisher","award":["2021APDA00RG00000209666"],"award-info":[{"award-number":["2021APDA00RG00000209666"]}],"id":[{"id":"10.13039\/100006309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS142876"],"award-info":[{"award-number":["R01NS142876"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.neuropharm.2026.111219","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:58:52Z","timestamp":1791356332000},"page":"111219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Adult-administered chronic nicotine remodels nigral dopaminergic and pedunculopontine cholinergic physiology"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9031-8105","authenticated-orcid":false,"given":"Rita Yu-Tzu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-6994","authenticated-orcid":false,"given":"Hassan","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skylar","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8854-9659","authenticated-orcid":false,"given":"Shirley","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9476-150X","authenticated-orcid":false,"given":"Rebekah","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111219_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.npp.1300366","article-title":"Behavioral and neurochemical vulnerability during adolescence in mice: studies with nicotine","volume":"29","author":"Adriani","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111219_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107669","article-title":"Assessing nicotine dependence using an oral nicotine free-choice paradigm in mice","volume":"157","author":"Bagdas","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111219_bib3","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s00018-019-03025-4","article-title":"Characterization of functional subgroups among genetically identified cholinergic neurons in the pedunculopontine nucleus","volume":"76","author":"Baksa","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.707789","article-title":"Alteration of mesopontine cholinergic function by the lack of KCNQ4 subunit","volume":"15","author":"Bayasgalan","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib5","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1443-24.2025","article-title":"Muscarinic receptor activation preferentially inhibits rebound in vulnerable dopaminergic neurons","volume":"45","author":"Beaver","year":"2025","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12102","article-title":"Action potential broadening in a presynaptic channelopathy","volume":"7","author":"Begum","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111219_bib7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/clpt.1984.67","article-title":"Daily intake of nicotine during cigarette smoking","volume":"35","author":"Benowitz","year":"1984","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2026.111219_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.expneurol.2015.11.004","article-title":"Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease","volume":"275","author":"Bensaid","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib9","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","article-title":"History of falls in parkinson disease is associated with reduced cholinergic activity","volume":"73","author":"Bohnen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2026.111219_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00121","article-title":"The M-current contributes to high threshold membrane potential oscillations in a cell type-specific way in the pedunculopontine nucleus of mice","volume":"9","author":"Bordas","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/jpet.106.106997","article-title":"Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotine","volume":"319","author":"Bordia","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111219_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151841","article-title":"Association between parkinson's disease and cigarette smoking, rural living, well-water consumption, farming and pesticide use: systematic review and meta-analysis","volume":"11","author":"Breckenridge","year":"2016","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.neuropharm.2026.111219_bib13","article-title":"Nicotine disrupts top-down habenular control over cholinergic inputs to the ventral tegmental area to increase motivational valence of food rewards","volume":"S0006\u20133223","author":"Campos","year":"2025","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111219_bib14","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3389\/fphar.2019.01494","article-title":"Pedunculopontine nucleus degeneration contributes to both motor and non-motor symptoms of parkinson's disease","volume":"10","author":"Chambers","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u201cRejuvenation\u201d protects neurons in mouse models of Parkinson's disease","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111219_bib16","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/ejn.16281","article-title":"Comparing tonic and phasic dendritic calcium in cholinergic pedunculopontine neurons and dopaminergic substantia nigra neurons","volume":"59","author":"Chen","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/mds.28051","article-title":"Pedunculopontine nucleus microstructure predicts postural and gait symptoms in parkinson's disease","volume":"35","author":"Craig","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2026.111219_bib18","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1523\/JNEUROSCI.5071-13.2014","article-title":"A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem","volume":"34","author":"Dautan","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nn.4335","article-title":"Segregated cholinergic transmission modulates dopamine neurons integrated in distinct functional circuits","volume":"19","author":"Dautan","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/syn.20650","article-title":"Effects of scopolamine on dopamine neurons in the substantia nigra: role of the pedunculopontine tegmental nucleus","volume":"63","author":"Di Giovanni","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2026.111219_bib21","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1523\/JNEUROSCI.5311-12.2013","article-title":"Calcium entry and \u03b1-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons","volume":"33","author":"Dryanovski","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00429-014-0897-3","article-title":"Adolescent nicotine-induced dendrite remodeling in the nucleus accumbens is rapid, persistent, and D1-dopamine receptor dependent","volume":"221","author":"Ehlinger","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2026.111219_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuroscience.2017.05.036","article-title":"Nicotine-induced and D1-receptor-dependent dendritic remodeling in a subset of dorsolateral striatum medium spiny neurons","volume":"356","author":"Ehlinger","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111219_bib24","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.cub.2017.05.084","article-title":"Differential control of dopaminergic excitability and locomotion by cholinergic inputs in mouse Substantia Nigra","volume":"27","author":"Estakhr","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002493","article-title":"The effects of NMDA subunit composition on calcium influx and spike timing-dependent plasticity in striatal medium spiny neurons","volume":"8","author":"Evans","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108156","article-title":"Functional dissection of basal ganglia inhibitory inputs onto substantia nigra dopaminergic neurons","volume":"32","author":"Evans","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2026.111219_bib27","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1523\/JNEUROSCI.0117-17.2017","article-title":"Dopamine inhibition differentially controls excitability of substantia nigra dopamine neuron subpopulations through T-Type calcium channels","volume":"37","author":"Evans","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib28","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.102308.3","article-title":"Inhibitory basal ganglia nuclei differentially innervate pedunculopontine nucleus subpopulations and evoke differential motor and valence behaviors","volume":"13","author":"Fallah","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.111219_bib29","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/brain\/awt172","article-title":"Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait","volume":"136","author":"Fling","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2026.111219_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1460-9568.2003.02511.x","article-title":"Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat","volume":"17","author":"Forster","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib31","doi-asserted-by":"crossref","first-page":"13814","DOI":"10.1523\/JNEUROSCI.1943-10.2010","article-title":"Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticity on dopamine neurons in the ventral tegmental area","volume":"30","author":"Gao","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib32","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1002\/hbm.25962","article-title":"In vivo structural connectome of arousal and motor brainstem nuclei by 7 tesla and 3 tesla MRI","volume":"43","author":"Garc\u00eda-Gomar","year":"2022","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuropharm.2026.111219_bib33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.neuro.2007.01.007","article-title":"Smoking during pregnancy: postnatal effects on arousal and attentional brain systems","volume":"28","author":"Garcia-Rill","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2026.111219_bib34","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0896-6273(00)80339-6","article-title":"Submillisecond AMPA receptor-mediated signaling at a principal neuron-interneuron synapse","volume":"18","author":"Geiger","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111219_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0896-6273(95)90076-4","article-title":"Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS","volume":"15","author":"Geiger","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111219_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fneur.2018.00455","article-title":"On cell loss and selective vulnerability of neuronal populations in parkinson's disease","volume":"9","author":"Gigu\u00e8re","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib37","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1523\/JNEUROSCI.2765-20.2021","article-title":"Voltage-gated potassium channels ensure action potential shape fidelity in distal axons","volume":"41","author":"Gonzalez Sabater","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/bs.pbr.2020.02.005","article-title":"Selective neuronal vulnerability in Parkinson's disease","volume":"252","author":"Gonzalez-Rodriguez","year":"2020","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111219_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2006.10.046","article-title":"Muscarinic and nicotinic responses in the developing pedunculopontine nucleus (PPN)","volume":"1129","author":"Good","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111219_bib40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0306-4522(89)90008-0","article-title":"Cholinergic projections to the substantia nigra from the pedunculopontine and laterodorsal tegmental nuclei","volume":"28","author":"Gould","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111219_bib41","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1523\/JNEUROSCI.09-10-03463.1989","article-title":"Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro","volume":"9","author":"Grace","year":"1989","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0006-8993(91)90646-D","article-title":"Chronic continuous nicotine treatment causes decreased burst firing of nigral dopamine neurons in rats partially hemitransected at the meso-diencephalic junction","volume":"562","author":"Grenhoff","year":"1991","journal-title":"Brain Res."},{"issue":"20","key":"10.1016\/j.neuropharm.2026.111219_bib124","doi-asserted-by":"crossref","first-page":"R1088","DOI":"10.1016\/j.cub.2016.06.041","article-title":"The basal ganglia over 500 million years","volume":"26","author":"Grillner","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1113\/jphysiol.2005.086835","article-title":"Kv7\/KCNQ\/M and HCN\/h, but not KCa2\/SK channels, contribute to the somatic medium after-hyperpolarization and excitability control in CA1 hippocampal pyramidal cells","volume":"566","author":"Gu","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46926","article-title":"Population adaptation in efficient balanced networks","volume":"8","author":"Gutierrez","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.111219_bib45","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1172\/JCI95898","article-title":"Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress","volume":"128","author":"Guzman","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2026.111219_bib46","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1523\/JNEUROSCI.2519-09.2009","article-title":"Robust pacemaking in substantia nigra dopaminergic neurons","volume":"29","author":"Guzman","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib47","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111219_bib48","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1523\/JNEUROSCI.3904-14.2015","article-title":"Tonic firing rate controls dendritic Ca2+ signaling and synaptic gain in substantia nigra dopamine neurons","volume":"35","author":"Hage","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib49","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease","volume":"52","author":"Hern\u00e1n","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuroscience.2014.07.002","article-title":"Pedunculopontine tegmental nucleus neurons provide reward, sensorimotor, and alerting signals to midbrain dopamine neurons","volume":"282","author":"Hong","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111219_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuroscience.2014.07.002","article-title":"Pedunculopontine tegmental nucleus neurons provide reward, sensorimotor, and alerting signals to midbrain dopamine neurons","volume":"282","author":"Hong","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111219_bib52","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.neuron.2014.09.038","article-title":"Control and plasticity of the presynaptic action potential waveform at small CNS nerve terminals","volume":"84","author":"Hoppa","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111219_bib53","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.neuron.2018.02.016","article-title":"Differential control of axonal and somatic resting potential by voltage-dependent conductances in cortical layer 5 pyramidal neurons","volume":"97","author":"Hu","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111219_bib54","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-4159.2009.06011.x","article-title":"Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys","volume":"109","author":"Huang","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111219_bib55","doi-asserted-by":"crossref","first-page":"9055","DOI":"10.1038\/s41598-021-88374-6","article-title":"Whole-brain mapping of monosynaptic inputs to midbrain cholinergic neurons","volume":"11","author":"Huerta-Ocampo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111219_bib56","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0454-19.2019","article-title":"Distribution of midbrain cholinergic axons in the thalamus","volume":"7","author":"Huerta-Ocampo","year":"2020","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2026.111219_bib57","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.neuron.2007.06.001","article-title":"The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity","volume":"54","author":"Isaac","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111219_bib58","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp.51.4.540","article-title":"The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease","volume":"51","author":"Jellinger","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111219_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114187","article-title":"Dopamine-sensitive neurons in the mesencephalic locomotor region control locomotion initiation, stop, and turns","volume":"43","author":"Ju\u00e1rez Tello","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2026.111219_bib60","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI42642","article-title":"Cholinergic mesencephalic neurons are involved in gait and postural disorders in parkinson disease","volume":"120","author":"Karachi","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2026.111219_bib61","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1471-4159.2006.04177.x","article-title":"Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRs","volume":"100","author":"Khwaja","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111219_bib62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1152\/jn.00574.2005","article-title":"Characterization of M-current in ventral tegmental area dopamine neurons","volume":"96","author":"Koyama","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib63","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55729","article-title":"Axonal mechanisms mediating \u03b3-aminobutyric acid receptor type A (GABA-A) inhibition of striatal dopamine release","volume":"9","author":"Kramer","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.111219_bib64","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neubiorev.2005.02.006","article-title":"Nicotine use in schizophrenia: the self medication hypotheses","volume":"29","author":"Kumari","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.111219_bib65","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1523\/JNEUROSCI.22-19-08653.2002","article-title":"Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area","volume":"22","author":"Laviolette","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib66","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/cne.903440205","article-title":"Pedunculopontine nucleus in the squirrel monkey: cholinergic and glutamatergic projections to the substantia nigra","volume":"344","author":"Lavoie","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1755-5949.2010.00142.x","article-title":"Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Lester","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2026.111219_bib68","first-page":"47","article-title":"Oscillations in pedunculopontine nucleus in Parkinson's disease and its relationship with deep brain stimulation","volume":"9","author":"Li","year":"2015","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2026.111219_bib69","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.archger.2015.08.004","article-title":"Association between cigarette smoking and Parkinson's disease: a meta-analysis","volume":"61","author":"Li","year":"2015","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.neuropharm.2026.111219_bib70","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.neuron.2022.07.003","article-title":"An inhibitory brainstem input to dopamine neurons encodes nicotine aversion","volume":"110","author":"Liu","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111219_bib71","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1073\/pnas.0510715103","article-title":"The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons","volume":"103","author":"Lodge","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111219_bib72","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fphar.2015.00089","article-title":"Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals","volume":"6","author":"Marchi","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fnana.2011.00022","article-title":"Topographical organization of the pedunculopontine nucleus","volume":"5","author":"Martinez-Gonzalez","year":"2011","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuropharm.2026.111219_bib74","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1111\/ejn.13066","article-title":"Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons","volume":"42","author":"Masi","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib75","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1038\/s41596-019-0240-9","article-title":"Advanced CUBIC tissue clearing for whole-organ cell profiling","volume":"14","author":"Matsumoto","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2026.111219_bib76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1152\/jn.1992.68.1.16","article-title":"Dual-component miniature excitatory synaptic currents in rat hippocampal CA3 pyramidal neurons","volume":"68","author":"McBain","year":"1992","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib77","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2005.05.041","article-title":"Periadolescent nicotine administration produces enduring changes in dendritic morphology of medium spiny neurons from nucleus accumbens","volume":"385","author":"McDonald","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.111219_bib78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0006-8993(84)91433-1","article-title":"Substantia nigra cell death from kainic acid or folic acid injections into the pontine tegmentum","volume":"298","author":"McGeer","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111219_bib79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuron.2017.02.027","article-title":"Rethinking the pedunculopontine nucleus: from cellular organization to function","volume":"94","author":"Mena-Segovia","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111219_bib80","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neuron.2007.08.022","article-title":"TARP subtypes differentially and dose-dependently control synaptic AMPA receptor gating","volume":"55","author":"Milstein","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111219_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.745783","article-title":"Sex differences in the nicotinic acetylcholine receptor system of rodents: impacts on nicotine and alcohol reward behaviors","volume":"15","author":"Moen","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib82","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41598-023-50526-1","article-title":"Subregion and sex differences in ethanol activation of cholinergic and glutamatergic cells in the mesopontine tegmentum","volume":"14","author":"Mulloy","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111219_bib83","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.1523\/JNEUROSCI.2199-07.2007","article-title":"Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path","volume":"27","author":"Nashmi","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib84","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1523\/JNEUROSCI.15-09-05859.1995","article-title":"Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area","volume":"15","author":"Oakman","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib85","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200311","article-title":"Transdermal nicotine treatment and progression of early parkinson's disease","volume":"2","author":"Oertel","year":"2023","journal-title":"NEJM Evid."},{"key":"10.1016\/j.neuropharm.2026.111219_bib86","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1038\/npp.2016.105","article-title":"Sex differences in midbrain dopamine D2-Type receptor availability and association with nicotine dependence","volume":"41","author":"Okita","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"Pt 9","key":"10.1016\/j.neuropharm.2026.111219_bib87","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/brain\/123.9.1767","article-title":"The pedunculopontine nucleus and Parkinson's disease","volume":"123","author":"Pahapill","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2026.111219_bib88","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1523\/JNEUROSCI.0277-05.2005","article-title":"Pedunculopontine tegmental nucleus controls conditioned responses of midbrain dopamine neurons in behaving rats","volume":"25","author":"Pan","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib89","series-title":"Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates","year":"2012"},{"key":"10.1016\/j.neuropharm.2026.111219_bib90","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0928-0987(93)90013-Z","article-title":"Plasma nicotine and cotinine concentrations in mice after chronic oral nicotine administration and challenge doses","volume":"1","author":"Pekonen","year":"1993","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib91","article-title":"Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease","volume":"2","author":"Perez-Lloret","year":"2016","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.neuropharm.2026.111219_bib92","first-page":"68","article-title":"Decoding brain state transitions in the pedunculopontine nucleus: cooperative phasic and tonic mechanisms","volume":"9","author":"Petzold","year":"2015","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2026.111219_bib93","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111219_bib94","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/34413","article-title":"Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine","volume":"391","author":"Picciotto","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111219_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuropharm.2026.111219_bib96","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.21900","article-title":"Nicotine and Parkinson's disease: implications for therapy","volume":"23","author":"Quik","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2026.111219_bib97","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1471-4159.2006.04078.x","article-title":"Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates","volume":"98","author":"Quik","year":"2006","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111219_bib98","article-title":"Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration","volume":"13","author":"Rademacher","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.111219_bib99","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.parkreldis.2008.01.006","article-title":"Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients","volume":"14","author":"Rinne","year":"2008","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2026.111219_bib100","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/archneur.64.7.990","article-title":"Pooled analysis of tobacco use and risk of Parkinson disease","volume":"64","author":"Ritz","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00295","article-title":"Dopamine and the brainstem locomotor networks: from lamprey to human","volume":"11","author":"Ryczko","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib101","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/cne.902590403","article-title":"Pedunculopontine tegmental nucleus of the rat: cytoarchitecture, cytochemistry, and some extrapyramidal connections of the mesopontine tegmentum","volume":"259","author":"Rye","year":"1987","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib102","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1523\/JNEUROSCI.2608-10.2011","article-title":"Remodeling of synaptic AMPA receptor subtype alters the probability and pattern of action potential firing","volume":"31","author":"Savtchouk","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib103","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/mds.27578","article-title":"Normal and pathological neuronal distribution of the human mesencephalic locomotor region","volume":"34","author":"S\u00e9bille","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2026.111219_bib104","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.70011","article-title":"Stereological analysis of cholinergic neurons within bilateral pedunculopontine nuclei in health and when affected by Parkinson's disease","volume":"35","author":"Sharma","year":"2025","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib105","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s13311-019-00830-4","article-title":"DREADD activation of pedunculopontine cholinergic neurons reverses motor deficits and restores striatal dopamine signaling in parkinsonian rats","volume":"17","author":"Sharma","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2026.111219_bib106","doi-asserted-by":"crossref","first-page":"10093","DOI":"10.1523\/JNEUROSCI.23-31-10093.2003","article-title":"Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation","volume":"23","author":"Stevens","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib107","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1523\/JNEUROSCI.3010-16.2017","article-title":"Inhibition of L-Type Ca2+ channels by TRPC1-STIM1 complex is essential for the protection of dopaminergic neurons","volume":"37","author":"Sun","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib108","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cell.2014.03.042","article-title":"Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis","volume":"157","author":"Susaki","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.111219_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/srep14099","article-title":"Modulation of AMPA receptor mediated current by nicotinic acetylcholine receptor in layer I neurons of rat prefrontal cortex","volume":"5","author":"Tang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111219_bib110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/brain\/awr315","article-title":"Alpha oscillations in the pedunculopontine nucleus correlate with gait performance in parkinsonism","volume":"135","author":"Thevathasan","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2026.111219_bib111","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1586\/ecp.11.27","article-title":"Can nicotine be used medicinally in Parkinson's disease?","volume":"4","author":"Thiriez","year":"2011","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111219_bib112","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1096\/fj.11-182824","article-title":"Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+","volume":"25","author":"Toulorge","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.111219_bib113","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1523\/JNEUROSCI.1914-21.2022","article-title":"Long-term inactivation of sodium channels as a mechanism of adaptation in CA1 pyramidal neurons","volume":"42","author":"Upchurch","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib114","doi-asserted-by":"crossref","first-page":"16345","DOI":"10.1523\/JNEUROSCI.3715-12.2012","article-title":"Ca(V)1.3-driven SK channel activation regulates pacemaking and spike frequency adaptation in mouse chromaffin cells","volume":"32","author":"Vandael","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.07.017","article-title":"Spike frequency adaptation is developmentally regulated in substantia nigra pars compacta dopaminergic neurons","volume":"192","author":"Vandecasteele","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111219_bib116","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cobeha.2018.04.004","article-title":"Sex differences in the nicotinic acetylcholine and dopamine receptor systems underlying tobacco smoking addiction","volume":"23","author":"Verplaetse","year":"2018","journal-title":"Curr. Opin. Behav. Sci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2008.01.021","article-title":"Voluntary oral nicotine intake in mice down-regulates GluR2 but does not modulate depression-like behaviors","volume":"434","author":"Vieyra-Reyes","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.111219_bib118","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1038\/s41467-018-04654-2","article-title":"Nicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum","volume":"9","author":"Wolfman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111219_bib119","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2016.03.028","article-title":"Cholinergic mesopontine signals govern locomotion and reward through dissociable midbrain pathways","volume":"90","author":"Xiao","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111219_bib120","doi-asserted-by":"crossref","first-page":"12428","DOI":"10.1523\/JNEUROSCI.2939-09.2009","article-title":"Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway","volume":"29","author":"Xiao","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111219_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41401-019-0299-4","article-title":"Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence","volume":"41","author":"Xiao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2026.111219_bib122","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(90)91236-A","article-title":"Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K","volume":"526","author":"Yamada","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111219_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109547","article-title":"CHRNA5 gene variation affects the response of VTA dopaminergic neurons during chronic nicotine exposure and withdrawal","volume":"235","author":"Yang","year":"2023","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:55:06Z","timestamp":1794027306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":125,"alternative-id":["S0028390826003941"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111219","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult-administered chronic nicotine remodels nigral dopaminergic and pedunculopontine cholinergic physiology","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111219"}}